<p>Listen to the Experts Discuss the Relevance of Timely and Optimal Glycemic Control with Empagliflozin and Linagliptin Combination in Management of T2DM.</p>

Rationality of the combination of SGLT2i and DPP-4i combinations | Dr. Suhas Erande & Dr. Ashwini Joshi

Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin &amp; Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin &amp; Linagliptin.